As a chemokine, the upregulation of CCL2 and CCL7 promotes the infiltration and activation of inflammatory cells during IPF progression, thereby sustaining lung inflammation (Deng et al., 2013; Krafft et al., 2013; Shinoda et al., 2009). Here, CCL7 is linked to idiopathic pulmonary fibrosis.